Body Text
Competitive advantage
- Extensive experience in clinical trials, diagnostic and implementation research
- Established clinical and surveillance networks across the Asia-Pacific
- Integrated framework for effective transdisciplinary infectious disease research
- Trusted and collaborative partnerships with community, decision makers, industry, academic, not-for-profit organisations, regulatory bodies, government and ministries of health
- Well characterised cohorts and linked data to model the scale, health-economic impact and real-world market potential of new biomedical technologies
Impact
- Sustainable scale-up of novel behavioural and biomedical interventions strategies
- Transformational improvements in health outcomes of affected communities globally
Successful outcomes
- Demonstration of impact of novel point-of-care diagnostic technologies for infections including chlamydia, gonorrhoea, human papilloma virus, hepatitis C virus and HIV infection among remote and marginalised communities
Capabilities and facilities
- Transdisciplinary field research
- Rapid and sustainable integration of biomedical interventions into health systems
- Field evaluation and implementat